Executive Summary
Across 50 filings dominated by neutral 13F-HR disclosures from institutions like Third Avenue Management (heavy industrials exposure: Tidewater $77M, Valaris $50M, Boise Cascade $43M) and SouthernSun (Louisiana-Pacific $35M, Crane NXT $32M), portfolio snapshots reveal stable conviction in select S&P 500 Industrials amid tech-heavy allocations, with TRUSTCO BANK holding GE Aerospace ($6.7M).
Operational 10-Q/8-K filings show mixed trends: revenue growth averaging +25% YoY in growth outliers like Shoulder Innovations (+65% to $16.7M Q1, guidance raised to $65-68M FY2026) and Pismo Coast Village (+13% to $2.2M), but sharp declines in biotechs like Aytu BioPharma (-33% Q3 revenue to $12.4M) and Semnur Pharma (opex +588% YoY). Banking peers reported robust net income gains (Finward +393% to $2.2M, Embassy +29% to $3.7M, Auburn +44% to $2.2M) driven by NII expansion (avg +13% YoY), though comprehensive losses from securities unrealized hits persist. Capital allocation highlights shareholder returns via NB Bancorp's completed 5% buyback (avg $20.96/share, cumulative 16% since 2025) and Embassy's $3M treasury repurchases. Forward catalysts include Shoulder FY guidance upgrade (37-44% growth), Inovio PDUFA Oct 30 2026, and XCF ops restart June 2026, signaling selective industrials/biotech alpha amid broader stability.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · 13F · 10-Q · 10-K
Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from May 12, 2026.
Investment Signals (12)
- Shoulder Innovations ↓ (BULLISH)▲
Q1 revenue +65% YoY to $16.7M (implants +51% units, ASP +9%), gross margin +70bps to 77.7%, FY2026 guidance raised to $65-68M (+37-44% YoY)
- NB Bancorp ↓ (BULLISH)▲
Completed 3rd buyback repurchasing 2.2M shares (5% outstanding) at $20.96 avg (cumulative 6.4M shares/16% since 2025 IPO, TBV $18/share)
- Finward Bancorp ↓ (BULLISH)▲
Q1 net income +393% YoY to $2.2M (EPS $0.52 vs $0.11), NII +13% to $15.1M, interest expense -15% to $7.7M, resumed $0.12/share dividend
- Embassy Bancorp ↓ (BULLISH)▲
Q1 net income +29.5% YoY to $3.7M (EPS $0.50 vs $0.38), NII +16.4% to $11.4M, deposits +2.5% QoQ to $1.68B, treasury buyback 150k shares/$3M
- Auburn National Bancorp ↓ (BULLISH)▲
Q1 net earnings +43.7% YoY to $2.2M (EPS $0.63 vs $0.44), NII +9.7% to $7.7M, loans +3% QoQ to $582M, PCL release $76k vs $10k provision
- Pismo Coast Village ↓ (BULLISH)▲
Q revenue +13% YoY to $2.2M (resort ops +15%), Q ops income $64k vs -$187k loss, 6-mo net income $111k vs -$160k loss, assets +3.7% to $31.6M
- Strategic Student & Senior Housing ↓ (BULLISH)▲
Q1 leasing revenue +13.1% YoY to $10.2M, ops income +203.7% to $949k, ops cash +68.2% to $1.5M despite net loss improvement
- Third Avenue Management ↓ (BULLISH)▲
Top holdings Tidewater $77M (921k shares), Valaris $50M (508k shares), Boise Cascade $43M (562k shares), all sole discretion signaling industrials conviction
- SouthernSun Asset Mgmt (BULLISH)▲
Industrials heavy w/ Louisiana-Pacific $35M, Crane NXT $32M, Darling Ingredients $48M, all sole voting amid $690M portfolio
- X4 Pharmaceuticals ↓ (BULLISH)▲
Annual meeting approvals: equity plan +1.5M shares (58.7M For), exec comp (70.9M For), auditors ratified (82.7M For), low opposition
- Kopernik Global ↓ (BULLISH)▲
QoQ share increases in industrials/energy adjacents (e.g. +4.2% NovaGold, +2.2% Intl Tower Hill Mines), no reductions across 31 holdings
- Inovio Pharmaceuticals ↓ (BULLISH)▲
Opex -13% YoY to $21.9M (R&D -12%, G&A -12%), cash $37.7M funds to Q1 2027, INO-3107 PDUFA Oct 30 2026
Risk Flags (10)
- Semnur Pharmaceuticals↓ [HIGH RISK]▼
Q1 net loss widened to -$4.6M (+588% YoY), R&D +577% to $1.3M, G&A +592% to $3.3M, ops cash use +570% to $2.7M, deficit -$25.3M
- Aytu BioPharma↓ [HIGH RISK]▼
Q3 revenue -33% YoY to $12.4M (ADHD -41%, Pediatric -70%), net loss -$5.6M vs +$4.0M profit, 9-mo loss -$14.2M vs +$6.3M, cash down to $26.7M
- CareView Communications↓ [HIGH RISK]▼
Q1 revenue -2% YoY to $2.2M (software bundles -17%), ops cash turned negative -$126k vs +$268k, cash to $1.4M, accrued interest +$0.8M to $23.7M
- Canary Marinade Solana ETF↓ [HIGH RISK]▼
Q1 net assets -40.5% to $1.1M (NAV -32% to $16.37), unrealized dep -539k on Solana, outflows -$229k, shares out -12.5% to 70k
- XCF Global↓ [MEDIUM RISK]▼
Debt/lien settlement via 37M shares dilutes but ongoing landlord/lender disputes, Reno facility ops delayed to June 2026 despite 38M gal capacity
- Eledon Pharmaceuticals↓ [MEDIUM RISK]▼
Q1 net loss widened to -$39M (R&D +27% YoY to $17.2M), cash -17% QoQ to $111M despite clinical wins, warrant non-cash loss $19M
- Dermata Therapeutics↓ [MEDIUM RISK]▼
Q1 ops cash use +28% YoY to $2.5M, cash -8% QoQ to $6.9M despite loss narrowing 20% to -$1.8M, SG&A +46% to $1.5M
- Finward Bancorp↓ [MEDIUM RISK]▼
Comprehensive loss -$1.8M (securities unrealized -$4.1M), equity -1.2% QoQ to $172M, deposits -0.8% to implied lower base
- Embassy Bancorp↓ [MEDIUM RISK]▼
Non-interest exp +9.5% YoY to $7.6M, comprehensive loss -$168k vs +$5.6M income, equity -2.2% QoQ to $125M
- Shoulder Innovations↓ [MEDIUM RISK]▼
Q1 op loss widened to -$9M (SG&A +73% to $18.2M, R&D +137% to $3.8M), cash -57% to $11.5M despite revenue beat
Opportunities (10)
- Shoulder Innovations/Guidance Raise↓ (OPPORTUNITY)◆
Q1 +65% revenue, FY guide $65-68M (+37-44% YoY) outperforms med device peers, gross margin 77.7%, watch for expansion
- NB Bancorp/Buyback Completion↓ (OPPORTUNITY)◆
Cumulative 16% shares repurchased since 2025 at $19.25 avg (TBV $18), signals undervaluation, potential for new program
- Inovio Pharmaceuticals/PDUFA↓ (OPPORTUNITY)◆
Cash funds to Q1 2027, INO-3107 BLA review PDUFA Oct 30 2026, opex -13% YoY efficiency, Akeso GBM collab
- XCF Global/Debt Restructuring↓ (OPPORTUNITY)◆
$16.7M debt cleared via shares at $0.451, Reno facility restart June 2026 (38M gal cap), balance sheet cleanup
- Third Avenue/Industrials Tilt↓ (OPPORTUNITY)◆
12.5% portfolio in offshore/energy industrials (Tidewater/Valaris), sole discretion, follow-on for sector rotation
- SouthernSun/Industrials Conviction↓ (OPPORTUNITY)◆
20%+ in building products/machinery (LA-Pacific, Crane NXT), stable sole holdings in $690M AUM
- Finward Bancorp/Turnaround↓ (OPPORTUNITY)◆
Net income +393% YoY on NII +13%, dividend resumption, loans/deposits stable, undervalued vs banking peers
- Pismo Coast Village/Recovery↓ (OPPORTUNITY)◆
Resort revenue +15% YoY to profitability ($64k ops income), assets +3.7%, capex up signaling growth
- Dermata Therapeutics/Loss Narrowing↓ (OPPORTUNITY)◆
Net loss -20% YoY to $1.8M (R&D -70%), ATM proceeds +$2M, equity + to $6.4M, pipeline catalyst potential
- Kopernik/Energy Add-Ons↓ (OPPORTUNITY)◆
QoQ increases in mining/energy (avg +3%), no sells, portfolio + resource tilt amid industrials adjacency
Sector Themes (6)
- Banking Net Income Surge◆
3/4 banks (Finward +393%, Embassy +30%, Auburn +44%) saw NII +10-16% YoY avg, but comprehensive losses from securities (-$4M avg unrealized), favoring core ops over total return plays
- Biotech Cash Burn Moderation◆
5/7 biotechs narrowed losses or cut opex (Inovio -13%, Dermata -20% R&D), cash runway to 2027 avg, but warrant volatility and high SG&A signal near-term dilution risks
- Institutional Industrials Stability◆
6/30+ 13Fs heavy in S&P Industrials (Third Ave 25% Tidewater/Valaris/Boise, SouthernSun 15% LA-Pacific/Crane, TRUSTCO GE Aerospace), sole discretion no QoQ changes, defensive rotation signal
- Revenue Growth in Niche Ops◆
4/10 10-Qs +13-65% YoY revenue (Shoulder med devices +65%, housing/resorts +13% avg), ops cash +68% in survivors, capex up signaling cap-intensive recovery
- Buyback Momentum◆
NB Bancorp 16% cumulative repurchase since 2025, Embassy $3M Q1 treasury, vs flat cap alloc elsewhere, undervaluation theme in financials/industrials
- Guidance/Catalyst Clustering◆
Shoulder FY raise +37-44%, Inovio PDUFA Oct 2026, XCF June ops, Eledon Phase 3 H2, building 2H 2026 biotech/industrial catalysts amid Q1 mixed prints
Watch List (8)
-
Monitor Q2 revenue vs $65-68M FY guide (37-44% growth), cash burn post $11.5M Q1, potential follow-on financing
-
FDA decision INO-3107 Oct 30 2026, Q2 cash burn ~$18M, Akeso collab progress into Q3
-
Reno facility return June 2026 post-debt clear, watch landlord/lender dispute resolution for dilution impact
-
Post-3rd program completion May 12 2026, monitor announcement of 4th program given TBV $18 vs avg repurchase $20
-
Q3 $2.4M launch revenue (1.3k scripts), watch Q4 ADHD/Pediatric stabilization vs -41/-70% declines
-
Cash to 2Q 2027, kidney/liver transplant data updates, Phase 3 initiation timing H2 2026
- Third Avenue Portfolio/Q2 13F👁
Tidewater/Valaris/Boise Cascade positions post-Q1 snapshot, any trims signal industrials peak
-
Q1 unrealized losses -$4M avg, watch Q2 comprehensive income and deposit trends amid rate environment
Filing Analyses
(50)
13-05-2026
X4 Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders on May 11, 2026, electing Gary J. Bridger, Ph.D., Françoise De Craecker, and Murray W. Stewart, M.D. as Class III directors until the 2029 Annual Meeting, with each receiving over 71 million 'For' votes amid low withheld votes. Stockholders ratified PricewaterhouseCoopers LLP as auditors (over 82 million 'For'), approved a 1,500,000 share increase to the Second Amended and Restated 2017 Equity Incentive Plan (58.7 million 'For' vs. 17.7 million 'Against'), and approved named executive officer compensation on an advisory basis (70.9 million 'For' vs. 5.4 million 'Against'). This 8-K/A solely corrects a typographical error in the original filing, listing Murray W. Stewart, M.D. instead of Michael S. Wyzga as a director nominee.
- · Proposal 2 (auditor ratification): 82,734,674 For; 43,841 Abstain; 68,992 Against; 0 broker non-votes.
- · Proposal 3 detailed votes: 58,679,552 For; 9,711 Abstain; 17,684,140 Against.
- · Proposal 4 detailed votes: 70,932,142 For; 20,692 Abstain; 5,420,569 Against.
13-05-2026
NWM Advisors, LLC, an investment advisor based in San Luis Obispo, CA, filed its Form 13F-HR disclosing total holdings of $109,780,627 across 23 positions as of March 31, 2026. Top holdings include Vanguard Admiral Fds Inc MidCp 400 Idx ($12,704,382, 111,130 shares), Berkshire Hathaway Inc Del Cl B New ($9,689,424, 20,220 shares), and Schwab Strategic Tr US Sml Cap ETF ($5,713,586, 196,478 shares). Other significant positions feature Apple Inc. ($4,764,745, 18,774 shares) and various ETFs focused on technology, innovation, and indices.
- · Filing submitted on May 13, 2026, for period ending March 31, 2026
- · All positions reported as sole discretionary holdings (SH SOLE)
- · Firm CIK: 0002098824, SEC file number: 028-26062
- · Business address: 735 Tank Farm Road, Suite 250, San Luis Obispo, CA 93401
13-05-2026
Semnur Pharmaceuticals reported a sharply widened net loss of $4,576 thousand for Q1 2026 compared to $665 thousand in Q1 2025, driven by R&D expenses surging to $1,266 thousand (up 577% YoY) and G&A expenses to $3,310 thousand (up 592% YoY), resulting in total operating expenses of $4,576 thousand (up 588% YoY). Total assets increased to $1,969 thousand from $1,346 thousand at December 31, 2025, with cash rising to $103 thousand from $20 thousand, but liabilities grew to $27,295 thousand from $22,096 thousand, largely due to a related party loan increase to $16,915 thousand, deepening stockholders' deficit to $25,326 thousand. While financing activities provided $2,753 thousand net cash (up from $394 thousand), operating cash use intensified to $2,670 thousand from $399 thousand.
- · Net cash used in operating activities: $2,670 thousand in Q1 2026 vs $399 thousand in Q1 2025.
- · Net cash provided by financing activities: $2,753 thousand in Q1 2026 (primarily $3,503 thousand from related party loans, offset by $750 thousand promissory note repayment).
- · Stock-based compensation: $1,484 thousand in Q1 2026 vs $92 thousand in Q1 2025.
- · Property and equipment, net remained flat at $750 thousand.
- · Net loss per share: $(0.02) basic and diluted in Q1 2026 vs $(0.01) in Q1 2025.
13-05-2026
Daner Wealth Management, LLC filed its 13F-HR on May 13, 2026, disclosing 88 equity positions held as of March 31, 2026, with a total market value of $170143367. Holdings are primarily in ETFs such as Dimensional US Core Equity 2 ETF (23433151 value, 543945 shares) and Vanguard Large Cap ETF (14456038 value, 42618 shares), alongside individual stocks including Apple Inc (1261402 value, 4279 shares), Amazon.com Inc (1333353 value, 5016 shares), and Nvidia Corp (1026631 value, 4650 shares). All positions reflect sole discretionary voting power with no reported shared voting authority or performance data.
- · Filing period end date: March 31, 2026
- · All holdings reported with sole discretionary voting power (SH SOLE) and zero shared voting authority
- · Business address: 11475 Great Oaks Way, Suite 340, Alpharetta, GA 30022
13-05-2026
First Citizens Bank & Trust Co filed its 13F-HR on May 13, 2026, disclosing approximately 925 equity positions held as of March 31, 2026. The portfolio is dominated by large-cap technology and consumer stocks, with top holdings including Apple Inc. valued at $153658678000 (605456 shares), Amazon.com Inc. at $62582635000 (300488 shares), Alphabet Inc. Cap Stk Cl C at $52411903000 (182709 shares), and Broadcom Inc. at $45700699000 (147655 shares). No period-over-period changes are detailed in the filing.
- · Filing CIK: 0001092203
- · Period end date: 2026-03-31
- · Filer address: PO BOX 29522 DAC61, Raleigh NC 27626
- · Business phone: 9197167505
13-05-2026
Third Avenue Management LLC filed its 13F-HR on May 13, 2026, reporting portfolio holdings as of March 31, 2026, with a total market value of $616036133 across 53 positions, all held with sole investment discretion. Largest holdings include Tidewater Inc. ($76964673, 921181 shares), Valaris Ltd. ($49822555, 508186 shares), and Boise Cascade Company ($42629293, 562021 shares). Other significant positions are Harley-Davidson Inc. ($29575187, 1462670 shares) and Robert Half, Inc. ($22959187, 903905 shares).
- · All 53 holdings reported with sole voting and investment discretion (SH SOLE).
- · Additional notable holdings: Five Point Holdings LLC - CL A (3861162 shares, $18688024 value), Compass Inc. CL A (187469 shares, $1370398 value).
13-05-2026
FORTRESS PRIVATE LEDGER, LLC filed its 13F-HR on May 13, 2026, reporting institutional holdings as of March 31, 2026, across 252 positions with a total market value of $320160550. Top holdings include Palantir Technologies Inc. CL A (40900473 value, 279604 shares), NVIDIA Corporation COM (17568338 value, 100736 shares SOLE and 300 shares Put), Capital Group Dividend Value ETF (15671958 value, 368405 shares), and Apple Inc. COM (13904839 value, 54789 shares). All positions are held with sole voting authority.
- · Filing period end date: 2026-03-31
- · Business address: 3110 Edwards Mill Rd, Ste 200, Raleigh, NC 27612
- · All reported positions held with sole voting authority (SH SOLE); minor put and call options noted for select names
13-05-2026
NB Bancorp, Inc. announced the completion of its third stock repurchase program on May 13, 2026, under which it repurchased 2,207,236 shares, or approximately 5% of its then outstanding common stock, at an average price of $20.96 per share. Cumulatively, since the first program announced on January 22, 2025, the Company has repurchased 6,371,044 shares, equivalent to 16% of its common shares issued in its initial public offering at the end of 2023, at a weighted average price of $19.25 per share. The Company's tangible book value per share was $18.00 as of March 31, 2026.
- · Date of earliest event reported: May 12, 2026
- · First stock repurchase program announced: January 22, 2025
- · Common shares issued in initial public offering at the end of 2023
13-05-2026
Summitas Investment Management LLC filed its 13F-HR on May 13, 2026, for the quarter ended March 31, 2026, disclosing total holdings valued at $127531044 with no period-over-period changes provided in the filing. Top positions include Vanguard S&P 500 ETF shares valued at 61485206, SPDR Gold Minishares (WORLD GOLD TR SPDR GLD MINIS) at 20359709, and Vanguard Information Technology ETF at 9886692. The portfolio features diversified ETF exposure across equities, gold, treasuries, emerging markets, and international assets, plus a small Apple Inc position at 1793280.
- · SPDR Gold Minishares: 219654 shares (sole)
- · Vanguard S&P 500 ETF: 102896 shares (sole)
- · Apple Inc: 7066 shares (sole)
- · All holdings reported as sole ownership with zero shared or other voting authority
13-05-2026
Parkside Financial Bank & Trust filed its 13F-HR report on May 13, 2026, disclosing holdings in 4123 securities with a total market value of $1,305,112,266 as of March 31, 2026. The portfolio features significant positions in large-cap technology stocks including Amazon.com Inc at $13,287,876, Alphabet Inc Cap Stk Cl A at $12,497,077, and Alphabet Inc Cap Stk Cl C at $6,946,774, alongside diversified exposure to healthcare, financials, and ETFs. No period-over-period changes are detailed in the filing.
- · Report period end date: March 31, 2026
- · Filing CIK: 0001455267
- · Business address: 8112 Maryland Ave Suite 101, Saint Louis, MO 63105
13-05-2026
Arvest Bank Trust Division disclosed 13F-HR holdings totaling $1,840,137,549 across 307 positions as of March 31, 2026, filed on May 13, 2026. The portfolio features large allocations to ETFs including iShares MSCI EAFE ETF ($125.9M), iShares Core S&P 500 ETF ($94.9M), and New World Fund Inc ($49.3M), alongside stocks such as Apple Inc ($46.8M), Nvidia Corp ($45.5M), and Microsoft Corp ($39.5M). No period-over-period changes or performance metrics are provided in the filing.
- · Filing date: May 13, 2026
- · Report period end: March 31, 2026
- · Former company name: Arvest Trust Co (name change date: November 19, 2014)
- · SEC file number: 028-16340
13-05-2026
SouthernSun Asset Management, LLC filed its 13F-HR report disclosing $689,910,992 in securities across 31 holdings as of March 31, 2026, all held solely with full voting authority. Top positions include Darling Ingredients Inc. ($48,249,804), Live Oak Bancshares Inc. ($34,179,135), Louisiana-Pacific Corp. ($35,346,970), and Crane NXT ($31,814,767). This routine quarterly disclosure provides a snapshot of the firm's equity portfolio concentrated in industrials and financials.
- · Filing covers period ending March 31, 2026, filed May 13, 2026
- · All holdings reported as SH SOLE with sole voting authority
- · Firm address: 240 Madison Avenue, Suite 800, Memphis, TN 38103
13-05-2026
NewEdge Wealth, LLC filed its quarterly 13F-HR on May 13, 2026, for the period ended March 31, 2026, disclosing a diversified portfolio of 1,128 securities with a total market value of $8,394,638,671. Major holdings include Alphabet Inc. CAP STK CL A (value $233,832,298), Amazon.com Inc. (value $140,047,336), and Broadcom Inc. (value $158,682,064), spanning equities, ETFs, and options across various sectors. No period-over-period changes are provided in the filing.
- · Filing as of date: May 13, 2026
- · Conformed period of report: March 31, 2026
- · Investment discretion: Sole voting authority on reported holdings
- · Business address: 2200 Atlantic Street, Stamford, CT 06902
13-05-2026
Wiregrass Investment Management LLC filed its 13F-HR report on May 13, 2026, for the quarter ended March 31, 2026, disclosing total holdings valued at $120637324 across 96 positions, all held as sole discretionary shares. Top holdings by value include Apple Inc. COM ($7617732, 30016 shares), NVIDIA Corporation COM ($7277775, 41730 shares), and Microsoft Corp. COM ($4719007, 12748 shares). The portfolio features a mix of large-cap stocks, ETFs, and smaller positions like Flowers Foods Inc. (217643 shares) and Xtant Med Hldgs Inc. (103000 shares), with no reported changes or performance metrics.
- · All 96 positions held as sole discretionary shares (SH SOLE) with zero shared, other manager, or performance rights.
- · Portfolio includes significant ETF exposure via iShares TR and SPDR/SPDR Series Trust products.
- · Smaller-cap or high-share-count positions: DEFI Technologies Inc. (60000 shares), PERRIGO CO PLC (47978 shares), TRUIST FINL CORP (42979 shares).
13-05-2026
Barbara Oil Co. filed its 13F-HR report disclosing 69 equity holdings totaling $259,489,718 as of March 31, 2026, with no changes in share positions across any holdings from the prior period, indicating flat portfolio activity. Largest positions include Johnson & Johnson (102,000 shares valued at $24,932,880), JPMorgan Chase & Co. (67,000 shares at $19,708,720), and Walmart Inc. (110,000 shares at $13,670,800). The portfolio remains diversified across sectors but shows no buys, sells, or other adjustments.
- · Report period end date: March 31, 2026
- · Filing date: May 13, 2026
- · All 69 holdings report zero changes in shares, puts, calls, or other manager activity
13-05-2026
For the three months ended March 31, 2026, Strategic Student & Senior Housing Trust, Inc. reported leasing and related revenues of $10,223,590, up 13.1% YoY from $9,040,180, leading to income from operations of $949,286, a 203.7% increase from $312,614. However, the company recorded a net loss of $302,308, an improvement from $1,042,092 YoY but still negative, with property operating expenses rising 8.8% to $6,887,268 and total equity declining to $7,004,057 from $7,687,989 at December 31, 2025. Cash from operations strengthened to $1,489,242, up 68.2% YoY.
- · Net cash provided by operating activities increased to $1,489,242 in Q1 2026 from $885,605 in Q1 2025.
- · Debt, net decreased to $101,947,470 as of March 31, 2026 from $102,406,080 at December 31, 2025.
- · Accumulated depreciation increased to $41,728,809 from $40,271,844 QoQ.
- · Cash and cash equivalents rose to $4,440,994 from $3,010,009 QoQ.
13-05-2026
Decheng Capital LLC filed its 13F-HR report for the quarter ended March 31, 2026, disclosing 14 equity holdings with a total market value of $661316235. The largest position is CG Oncology Inc. at $431234558 (6371669 shares), followed by Nuvation Bio Inc. at $111344543 (25954439 shares). All holdings are reported as sole ownership with sole voting authority and no performance changes or comparisons provided in the filing.
- · Holdings also include Arcus Biosciences, Inc. ($10320890, 477819 shares), BeyondSpring Inc. ($6233152, 3800702 shares), and Upstream Bio Inc. ($24523812, 2724868 shares).
- · Firm address: 3000 Sand Hill Rd, Building 2, Suite 110, Menlo Park, CA 94025.
- · Report filed on May 13, 2026, for period ending March 31, 2026.
13-05-2026
Blacksheep Fund Management Ltd filed a 13F-HR report disclosing total equity holdings of $247201034 as of March 31, 2026, across 8 positions with sole voting authority. Largest holdings include TransDigm Group Inc ($53027056), Microsoft Corp ($48173924), and Mastercard Incorporated ($43795199). No period-over-period changes or performance metrics are provided in the filing.
- · Holdings as of period end: 2026-03-31
- · Filing date: 2026-05-13
- · Filer CIK: 0001800249
- · Share counts: Grindr Inc (1241080 shares), Tucows Inc (1091985 shares), Liberty Media LBTY ONE S C (351706 shares), Microsoft Corp (130140 shares), Visa Inc (100710 shares), Mastercard (87650 shares), TransDigm Group (45754 shares), Liberty Media LBTY ONE S A (104010 shares)
13-05-2026
Fairbanks Capital Management, Inc. filed its 13F-HR report on May 13, 2026, disclosing 51 equity holdings as of March 31, 2026, with a total market value of 159797796 USD. Top holdings by value include QUALCOMM INC (9997959 USD, 77635 shares), ALLIANCE RES PARTNER L P UT LTD PART (7823318 USD, 282941 shares), ALPHABET INC CAP STK CL C (7161746 USD, 24966 shares), TAIWAN SEMICONDUCTOR MFG LTD (7511614 USD, 22227 shares), and MICROSOFT CORP (7273242 USD, 19648 shares). All positions are held with sole voting and investment discretion.
- · All holdings managed with sole voting (0) and sole investment discretion (0).
- · Firm address: 16236 San Dieguito Rd., Rancho Santa Fe, CA 92091.
- · Contact phone: 858-759-0617.
- · Other notable holdings: GameStop CL A (1699637 USD, 73769 shares), iShares Bitcoin Trust ETF (1472369 USD, 38323 shares).
13-05-2026
Godshalk Welsh Capital Management, Inc. filed its 13F-HR on May 13, 2026, disclosing 129 equity positions held as of March 31, 2026, all with sole voting authority and no shared or none authority positions. Top holdings by market value include Apple Inc. (8197925 USD, 32302 shares), Microsoft Corporation (7334919 USD, 19815 shares), and Alphabet Inc. Cl A (5139847 USD, 17874 shares), alongside a diversified mix of large-cap stocks, ETFs, and fixed-income oriented iShares iBonds ETFs. No prior period comparisons are available in the filing.
- · Report period end date: 2026-03-31
- · Filing as of date: 2026-05-13
- · All 129 positions held as sole discretionary accounts
- · Portfolio includes significant allocations to short-term municipal and corporate bond ETFs (e.g., iShares iBonds series totaling over 1M USD each in multiple maturities)
13-05-2026
Alpha Financial Partners LLC filed its 13F-HR disclosing $168,925,796 in total holdings across 103 positions as of March 31, 2026. The portfolio is heavily weighted toward ETFs including iShares Core U.S. Aggregate Bond ETF at $17,339,515 and iShares National Muni Bond ETF at $5,922,491, with notable equity positions in Apple Inc ($1,966,154), JPMorgan Chase & Co ($3,633,275), and iShares Core S&P 500 ETF ($45,048,196). No prior period comparisons or performance changes are provided in this routine quarterly snapshot.
- · Filing date: May 13, 2026
- · Report period end: March 31, 2026
- · All positions held with sole voting power
- · Heavy allocation to fixed income and broad market ETFs
13-05-2026
CareView Communications Inc reported Q1 2026 total revenues of $2,191,342, down 2% YoY from $2,239,347, driven by a 17% decline in sales-based software bundle revenue to $935,654 despite growth in subscription-based revenue (+3% to $1,017,483) and equipment packages (+97% to $238,205). Operating income improved to $30,843 from a $134,710 loss YoY due to 9% lower operating expenses, resulting in a smaller net loss of $756,200; however, cash flows from operations turned negative at $126,166 from $267,881 YoY, reducing cash to $1,411,435.
- · Accrued interest payable increased to $23,698,264 as of Mar 31, 2026 from $22,896,139 at Dec 31, 2025.
- · Stock-based compensation expense of $150,302 in Q1 2026.
- · Contract liabilities balance decreased to $2,618,960 end Q1 2026 from $3,158,474 end Q1 2025.
13-05-2026
Militia Capital Management LLC filed its 13F-HR on May 13, 2026, disclosing $442,685,358 in holdings across 257 positions as of March 31, 2026, all with sole voting power. Top holdings include EA Series Trust Militia Long/Short ($15,469,781), Energy Transfer LP ($11,580,000), iShares Bitcoin Trust ($9,794,718), and Grupo Aeroportuario del Centro Norte ($9,732,087). No period-over-period changes are provided in this filing.
- · Filer address: 500 W. 2nd Street Suite 1900, Austin, TX 78701
- · All 257 positions held with sole voting and sole investment discretion
- · Central Index Key: 0002130487
- · SEC File Number: 028-26906
13-05-2026
Kopernik Global Investors, LLC disclosed $1.43B in total 13F portfolio value as of March 31, 2026 (Q1 2026), across 31 holdings, with top positions in Seabridge Gold Inc ($208M), Range Resources Corp ($189M), KT Corp ($114M), Nutrien Ltd ($107M), and Expand Energy Corporation ($89M). The firm increased shares in most positions quarter-over-quarter (QoQ), including +616,756 shares in Northern Dynasty Minerals Ltd (+1.9%), +379,221 shares in International Tower Hill Mines (+2.2%), and +263,549 shares in NovaGold Resources Inc (+4.2%), while positions like AbbVie, Amgen, Apple, and AutoZone put options and Newmont Corp remained flat at 0% change. No share reductions were reported in the listed holdings.
- · Portfolio heavily weighted toward mining and energy stocks (e.g., Seabridge Gold, Northern Dynasty Minerals, NovaGold Resources, Range Resources).
- · All reported share changes involved additions (no removals), with REM column at 0 across positions.
- · Put options held in AbbVie Inc (4,600 shares), Amgen Inc (4,200 shares), Apple Inc (5,000 shares), and AutoZone Inc (400 shares), unchanged QoQ.
13-05-2026
Impala Asset Management LLC disclosed 26 equity positions with a total market value of $214,629,764 in its 13F-HR filing as of March 31, 2026. Largest holdings include Century Alum Co ($57,222,750 market value, 975,000 shares), Ero Copper Corp ($27,391,591, 1,027,956 shares), and Buckle Inc ($21,129,948, 419,578 shares). The portfolio also features options positions such as Tronox Holdings PLC calls ($11,413,314, 1,168,200) and Huntsman Corp calls ($6,002,810, 451,000).
- · Filing submitted on May 13, 2026, for period ending March 31, 2026
- · All positions reported as sole voting/dispositive power with no shared power
13-05-2026
AYTU BioPharma's Q3 FY2026 net revenue declined 33% YoY to $12,411 thousand from $18,452 thousand, with ADHD Portfolio down 41% to $9,093 thousand, Pediatric Portfolio down 70% to $921 thousand, offset partially by new EXXUA revenue of $2,397 thousand; for the nine months, revenue fell 19% to $41,464 thousand. The company reported a Q3 net loss of $5,618 thousand versus prior year profit of $3,994 thousand, and nine-month net loss of $14,237 thousand versus $6,256 thousand profit, with operating cash use improving to $1,125 thousand from $4,740 thousand. Stockholders' equity rose to $35,143 thousand from $18,966 thousand at June 30, 2025, boosted by warrant exercises and derivative reclassification.
- · Total current liabilities decreased to $59,972 thousand from $63,064 thousand at June 30, 2025.
- · Derivative warrant liabilities fell sharply to $2,182 thousand from $26,334 thousand.
- · Inventories declined to $7,460 thousand from $11,434 thousand, with finished goods down significantly.
- · Net cash used in operating activities for nine months improved to $1,125 thousand from $4,740 thousand.
13-05-2026
May Barnhard Investments LLC filed a 13F-HR disclosing total holdings of $205,995,507 across 84 positions as of March 31, 2026. The portfolio is dominated by ETFs including Schwab Strategic Trust US Large Cap ETF ($13,502,197), Schwab Strategic Trust US Large Cap Growth ETF ($9,935,428), and various iShares and Vanguard funds, with individual stocks like Apple Inc. ($2,588,480 for 10,199 shares) and Amazon.com Inc. ($873,901 for 4,196 shares). No period-over-period changes are reported in this filing.
- · Filing date: May 13, 2026
- · Report period end: March 31, 2026
- · Largest individual stock holding: Apple Inc. (10,199 shares)
- · NVIDIA Corporation: 4,399 shares valued at $767,186
- · All holdings reported as sole voting authority
13-05-2026
Embassy Bancorp, Inc. reported Q1 2026 net income of $3,739 thousand (up 29.5% YoY from $2,887 thousand) and basic/diluted EPS of $0.50 (up from $0.38), driven by net interest income growth of 16.4% YoY to $11,441 thousand. Total assets increased 2.3% QoQ to $1,841,972 thousand, with deposits up 2.5% to $1,681,828 thousand and loans up 0.4% to $1,283,791 thousand. However, comprehensive loss was $168 thousand (vs. $5,642 thousand income YoY) due to $3,907 thousand net unrealized loss on securities, resulting in stockholders' equity declining 2.2% QoQ to $124,807 thousand; non-interest expenses also rose 9.5% YoY to $7,559 thousand.
- · Provision for credit losses: $20 thousand in Q1 2026 (down from $47 thousand YoY)
- · Net cash provided by operating activities: $4,831 thousand in Q1 2026 (up from $2,684 thousand YoY)
- · Treasury stock purchases: 150,000 shares for $2,959 thousand in Q1 2026
- · Cash and cash equivalents: $141,833 thousand as of March 31, 2026 (up $28,974 thousand QoQ)
13-05-2026
Bradley & Co. Private Wealth Management, LLC filed a 13F-HR report disclosing total holdings valued at $189,693,689 across 266 positions as of March 31, 2026, with all positions held under sole discretionary voting power. Notable positions include Alphabet Inc Class C ($14,911,738), Apple Inc ($14,060,043), Berkshire Hathaway Inc Cl B ($12,054,978), JPMorgan Chase & Co ($11,518,309), and Costco Wholesale Corp ($11,639,052). No period-over-period changes are indicated in this snapshot filing.
- · Filing date: May 13, 2026
- · Report period end: March 31, 2026
- · CIK: 0001861678
- · State of incorporation: FL
- · Business address: 801 Brickell Avenue Suite 800, Miami, FL 33131
13-05-2026
Martingale Asset Management L P disclosed 794 equity holdings totaling $3,987,776,991 in its 13F-HR filing as of March 31, 2026. Top positions include Apple Inc. ($55,438,142), Alphabet Inc. Class A ($46,509,955), Amazon.com Inc. ($44,252,377), Berkshire Hathaway Inc. Class B ($40,237,466), and Cisco Systems Inc. ($38,979,587). The portfolio spans diverse sectors with varying voting authority splits across holdings.
- · Report period end date: March 31, 2026
- · Filing date: May 13, 2026
- · Filer CIK: 0000936944
- · Business address: 888 Boylston Street, Suite 1400, Boston, MA 02199
- · Phone: 617-424-4700
13-05-2026
Wilkinson Global Asset Management LLC filed its 13F-HR disclosing $1,312,839,930 in equity holdings as of March 31, 2026, across 91 positions primarily in technology and consumer stocks. Top holdings include TJX Cos Inc ($107,184,891), Taiwan Semiconductor Manufacturing ($79,181,009), Apple Inc ($75,453,290), NVIDIA Corporation ($74,686,102), and Microsoft Corp ($73,490,961). The filing provides a snapshot with no period-over-period comparisons available.
- · Holdings managed across SOLE discretionary and OTR (other reported) accounts
- · Filing CIK: 0001764000, SEC File Number: 028-19149
- · Business address: 437 Madison Avenue, 33rd Floor, New York, NY 10022
13-05-2026
XCF Global, Inc. (SAFX) entered a definitive agreement to satisfy approximately $16.7 million of outstanding debt and property liens owed to Encore DEC and related creditors through the issuance of 37.03 million shares of Class A common stock at a conversion price of $0.451 per share, strengthening its balance sheet and financial flexibility. This follows a recent forbearance arrangement with the landowner and reflects confidence from key stakeholder Randy Soule, New Rise founder. The company highlighted ongoing challenges including disputes with its landlord and primary lender, while focusing on operational execution at its New Rise Renewables Reno facility with 38 million gallons per year permitted capacity and expected return to operations in June 2026.
- · Agreement involves XCF subsidiary New Rise Renewables Reno LLC
- · Transaction eliminates liens from prior engineering and construction activity
- · Ongoing disputes with landlord on ground lease and primary lender on loans
- · Expected return to operations of New Rise Reno facility in June 2026
13-05-2026
Pismo Coast Village Inc reported results for the three and six months ended March 31, 2026, with quarterly revenue increasing 13% YoY to $2,223,000 from $1,966,000, driven by 15% growth in resort operations to $2,031,000, while achieving operating income of $64,000 versus a $187,000 loss prior year. For the six months, revenue rose 13% to $4,536,000, with net income of $111,000 versus a $160,000 loss, but retail operations declined 4% to $279,000 and property lease income fell 11% to $101,000, resulting in a modest six-month operating loss of $14,000. Total assets grew to $31,649,000 from $30,529,000 at September 30, 2025.
- · Net cash provided by operating activities was $1,543,000 for six months ended March 31, 2026, slightly down from $1,545,000 prior year.
- · Capital expenditures of $213,000 in six months ended March 31, 2026, up from $113,000.
- · Property and equipment, net decreased slightly to $16,573,000 from $16,588,000.
- · Customer deposits increased to $3,977,000 from $2,596,000.
13-05-2026
Consultiva Wealth Management, Corp. filed its 13F-HR on May 13, 2026, disclosing 264 equity holdings totaling $34,571,284 as of March 31, 2026, all with sole voting and investment discretion. The portfolio is diversified across individual stocks and ETFs, with largest positions in Vanguard S&P 500 ETF ($3,488,497 for 5,838 shares), NVIDIA Corporation ($3,461,840 for 19,850 shares), Alphabet Inc. Class A ($1,984,164 for 6,900 shares), and Apple Inc. ($1,160,835 for 4,574 shares). No changes or prior period comparisons were reported in the filing.
- · Filer CIK: 0001845849; EIN: 660569863; State of Incorporation: PR
- · Business Address: 250 Ave Munoz Rivera, Suite 1420, San Juan, PR 00918; Phone: 787-763-5868
- · SEC File Number: 028-20984; Conformed Period of Report: 03-31-2026
13-05-2026
Decas Capital LLC filed a 13F-HR report on May 13, 2026, disclosing its equity holdings as of March 31, 2026. The filing indicates no reportable positions, with all shared and sole voting/dispositive power values reported as zero, potentially due to confidential treatment or holdings below the reporting threshold. Managed by Robert D. Hardie, the firm is based in Charlottesville, VA.
- · Central Index Key (CIK): 0001920624
- · SEC File Number: 028-22485
- · Business Address: 210 Ridge McIntire Road, Suite 350, Charlottesville, VA 22903
- · Business Phone: 434-906-1000
13-05-2026
Aytu BioPharma reported Q3 FY2026 total net revenue of $12.4 million, down 33% YoY from $18.5 million, primarily due to declines in the ADHD Portfolio ($9.1 million vs. $15.4 million, -41% YoY) from sales force reprioritization and generic competition, and Pediatric Portfolio ($0.9 million vs. $3.1 million, -70% YoY) from payor changes and returns. However, new EXXUA launch generated $2.4 million in net revenue with strong early adoption, including over 1,300 prescriptions from more than 450 prescribers and over 3,200 units sold. Adjusted EBITDA was $(2.8) million versus $3.9 million prior year, with net loss of $5.6 million (vs. $4.0 million income) and cash balance of $26.7 million.
- · On March 31, 2026, amended warrants reduced derivative warrant liabilities by $26.4 million and increased stockholders’ equity by the same amount.
- · Cash and cash equivalents decreased to $26.7 million at March 31, 2026, from $31.0 million at June 30, 2025.
- · $1.3 million derivative warrant liability loss in Q3 FY2026 due to stock price increase (vs. $2.3 million gain prior year).
- · $0.7 million inventory write-down in cost of goods sold related to Adzenys shift to generics.
13-05-2026
Finward Bancorp reported net income of $2,242 thousand for the three months ended March 31, 2026, up 393% YoY from $455 thousand, driven by net interest income growth of 13% to $15,071 thousand and a 15% decline in interest expense to $7,650 thousand. However, the company recorded a comprehensive loss of $1,809 thousand due to $4,051 thousand in net unrealized losses on securities available-for-sale, contributing to a QoQ decline in stockholders' equity to $172,400 thousand from $174,663 thousand at year-end 2025. Non-interest expenses rose slightly 2% YoY to $14,768 thousand, while deposits decreased by $7,900 thousand.
- · Basic and diluted EPS $0.52 in Q1 2026 vs $0.11 in Q1 2025
- · Dividends declared $0.12 per share in Q1 2026 vs $0
- · Provision for credit losses $55 thousand in Q1 2026 vs $454 thousand in Q1 2025
- · Gross unrealized losses on securities $60,129 thousand at March 31, 2026 vs $54,801 thousand at Dec 31, 2025
- · Proceeds from borrowed funds $15,000 thousand in Q1 2026
13-05-2026
Eledon Pharmaceuticals reported strong clinical progress in Q1 2026, including 100% insulin independence in 10 of 12 type 1 diabetes patients treated with tegoprubart post-islet transplantation, FDA Orphan Drug designation for liver transplantation, and improved eGFR from 67.0 to 74.2 mL/min/1.73 m² in 24-month Phase 1b kidney transplant data. However, cash and equivalents declined 17% QoQ to $111.1M from $133.3M, R&D expenses rose 27% YoY to $17.2M from $13.5M, and net loss widened to $39.0M from $6.5M YoY, driven by a $19.0M non-cash warrant liability loss. The company expects cash to fund operations into 2Q 2027 amid planned Phase 3 initiation and new trials.
- · No episodes of biopsy-proven acute rejection, graft loss, death, new-onset diabetes mellitus, or de novo donor-specific antibody formation in Phase 1b 24-month data.
- · Excluding non-cash warrant changes, adjusted net loss was $20.1M in Q1 2026 vs $16.6M in Q1 2025.
- · Total assets $146.667M as of March 31, 2026 vs $169.009M as of December 31, 2025.
- · Warrant liabilities increased to $30.378M as of March 31, 2026 from $11.416M as of December 31, 2025.
13-05-2026
Auburn National Bancorporation reported Q1 2026 net earnings of $2,198 thousand, up 43.7% YoY from $1,530 thousand, supported by 9.7% YoY growth in net interest income to $7,733 thousand and 19.5% increase in noninterest income, while noninterest expense remained flat at $5,901 thousand. Loans grew 3.0% QoQ to $582,040 thousand and deposits rose 0.9% to $931,109 thousand, but securities available-for-sale declined 2.8% QoQ to $226,785 thousand. Comprehensive income fell to $1,949 thousand from $5,766 thousand YoY due to a $249 thousand unrealized loss on securities.
- · Provision for credit losses released $76 thousand in Q1 2026 vs $10 thousand in Q1 2025.
- · EPS basic and diluted $0.63 in Q1 2026 vs $0.44 in Q1 2025.
- · Cash dividends paid $0.27 per share in both Q1 2026 and Q1 2025.
- · 3,493,256 common shares outstanding as of May 12, 2026.
13-05-2026
TradeLink Capital LLC filed its 13F-HR on May 13, 2026, disclosing holdings as of March 31, 2026, in 34 positions consisting of common stocks and long put options, all held with sole voting authority. Largest positions by market value include Watsco Inc at $1,105,000, Bio-Techne Corp at $1,066,000, and LKQ Corp at $755,000. The portfolio features protective put options on several holdings such as ENVA, GPC, GXO, and WEX, with no prior period comparisons provided.
- · All positions held as SH SOLE with 100% voting authority (0 1 0)
- · Filer CIK: 0001642044, incorporated in DE, headquartered in Chicago, IL
- · Put option expirations primarily May 15, 2026, except TECH Apr 17, 2026
13-05-2026
First Trust Bank, Ltd. filed a 13F-HR on May 13, 2026, disclosing $50,880,996 (in $000 USD) in total holdings as of March 31, 2026, across 7 sole positions with no reported changes, puts, or options. Key holdings include Hesai Group Sponsored ADS at 3,466,265 ($000), iShares MSCI GBL ETF at 6,089,197 ($000), and iShares JPMorgan USD Emerging Markets ETF at 14,840,940 ($000). The portfolio features significant allocations to ETFs, gold shares, energy sector ETF, and Synopsys Inc.
- · All positions reported as sole ownership with zero shares in put/call options.
- · Filing includes references to multiple other investment managers under 13F combination report structure.
13-05-2026
Sagewood Asset Management LP filed its quarterly 13F-HR report as of March 31, 2026, disclosing a portfolio of 337 equity positions with a total market value of $319235858. All reported holdings are with sole voting power, featuring top positions in Apple Inc. (47579 shares valued at $12075074), NVIDIA Corporation (67661 shares valued at $11800078), and Microsoft Corp. (26804 shares valued at $9922037). No changes from prior periods or performance metrics are detailed in the filing.
- · Filing submitted on May 13, 2026, for period ending March 31, 2026
- · All holdings reported with sole voting power (SH SOLE column populated, sharing and other columns at 0)
13-05-2026
DLD Asset Management, LP filed its 13F-HR on May 13, 2026, disclosing holdings as of March 31, 2026, with a total portfolio market value of $1,099,755,659 across 357 positions. The portfolio features heavy exposure to SPACs (e.g., units, warrants, rights, and Class A shares), put and call options, and fixed income notes, with no reported changes in sole voting authority for any positions. Notable holdings include EchoStar notes ($143M market value), BofA notes ($45M), Bank of America puts ($12M), and Bitdeer puts ($12M), alongside equity positions like Apartment Income REIT (1.07M shares) and ELME Communities (1.09M shares).
- · Report period end date: March 31, 2026
- · Filing date: May 13, 2026
- · All positions reported as SOLE voting authority with 0 shared and 0 other manager authority
- · Business address: 150 East 52nd Street, Suite 32001, New York, NY 10022
13-05-2026
TRUSTCO BANK CORP N Y filed a 13F-HR on May 13, 2026, disclosing its institutional investment holdings as of March 31, 2026, totaling 112607669 in value (reported in $000s). The portfolio consists of 135 positions predominantly in large-cap U.S. equities such as Applied Materials Inc. (7809218 value), GE Aerospace (6709741 value), and Apple Inc. (5773214 value), with a notable self-holding in TRUSTCO BANK CORP NY common stock (4022638 value). No period-over-period changes are detailed in this snapshot filing.
- · Filing CIK: 0000357301
- · Business address: 6 Metro Park Road, Albany, NY 12205
- · Phone: 518-377-3311
- · SEC file number: 028-06657
13-05-2026
The Canary Marinade Solana ETF (SOLC) reported net assets of $1,145,618 as of March 31, 2026, down 40.5% from $1,926,808 at December 31, 2025, with NAV per share declining 32.0% to $16.37 from $24.09 amid significant unrealized depreciation of $539,756 on Solana holdings. While staking income provided $21,975 in net investment income, operations resulted in a net decrease of $551,958 due to realized losses of $34,177, and capital share transactions showed net outflows of $229,232 from redemptions exceeding sales. Shares outstanding fell 12.5% to 70,000 from 80,000.
- · Sponsor fees of $1,691 fully waived for the quarter ended March 31, 2026.
- · 20,000 shares redeemed in January 2026 at average price of $25.49 per share; no redemptions in February or March 2026.
- · Investments in Solana at cost: $1,854,598 at March 31, 2026 (vs. fair value $1,145,618); $2,096,032 at December 31, 2025 (vs. fair value $1,926,808).
13-05-2026
Shoulder Innovations reported first quarter 2026 net revenue of $16.7 million, up 65% year-over-year from $10.1 million, driven by a 51% increase in implant systems sold to 2,184 and a 9% rise in average selling price to $7,650, with gross margin expanding slightly to 77.7%. However, selling, general and administrative expenses surged 73% to $18.2 million and research and development expenses jumped 137% to $3.8 million, resulting in an operating loss of $9.0 million compared to $4.3 million in the prior year and a net loss of $8.4 million. The company raised its full year 2026 net revenue guidance to $65 million to $68 million, representing 37% to 44% growth over 2025.
- · Adjusted EBITDA loss of $7.0 million in Q1 2026 vs $3.5 million in Q1 2025.
- · Cash and cash equivalents decreased to $11.5 million from $26.9 million at Dec 31, 2025.
- · Weighted average shares outstanding: 20,653,035 in Q1 2026 (basic and diluted).
- · Net loss per share: $(0.41) in Q1 2026 vs $(52.13) in Q1 2025.
13-05-2026
Monashee Investment Management LLC filed its 13F-HR on May 13, 2026, disclosing 45 equity and debt holdings as of March 31, 2026, with a total portfolio market value of $183.8 billion. Top positions include Terns Pharmaceuticals Inc. ($15.8B, 300,000 shares), Nextera Energy Inc. Unit 02/15/2029 ($15.2B, 299,970 shares), Medline Inc. ($13.4B, 300,000 shares), NRG Energy Inc. ($12.4B, 85,000 shares), Forgent Power Solutions Inc. ($10.2B, 350,000 shares), and Solid Biosciences Inc. ($10.2B, 1,420,295 shares). No prior period comparisons or changes are provided in the filing.
- · All reported holdings are held on a sole discretionary basis
- · SEC file number: 028-16854
- · Investment adviser CIK: 000163148
13-05-2026
INOVIO reported Q1 2026 financial results showing total operating expenses decreased 13% YoY to $21.9 million, with R&D expenses down to $14.1 million from $16.1 million and G&A down to $7.9 million from $9.0 million; however, net loss remained flat at $19.7 million YoY and revenue was $0 compared to $65,343. Cash, cash equivalents, and short-term investments stood at $37.7 million as of March 31, 2026 (excluding $16.0 million net proceeds from April offering), sufficient to fund operations into Q1 2027 amid ongoing FDA review of INO-3107 BLA (PDUFA October 30, 2026) and a new collaboration with Akeso for INO-5412 in GBM.
- · Q2 2026 operational net cash burn estimated at approximately $18 million
- · BLA for INO-3107 accepted December 2025 under accelerated approval with mid-cycle review completed
13-05-2026
Dermata Therapeutics reported a narrowed net loss of $1,847,706 for Q1 2026, improving 19.8% YoY from $2,303,587 in Q1 2025, primarily due to a 70.1% reduction in R&D expenses to $383,724, though SG&A expenses rose 45.7% to $1,542,658. Cash and equivalents decreased $576,696 QoQ to $6,945,282 as of March 31, 2026 from $7,521,978 at December 31, 2025, amid higher net cash used in operations of $2,479,718 versus $1,934,066 YoY. Stockholders' equity increased to $6,413,003, supported by $1,994,051 net proceeds from ATM common stock sales.
- · Weighted-average shares outstanding increased to 3,858,921 in Q1 2026 from 515,465 in Q1 2025, improving EPS to $(0.48) from $(4.47).
- · New inventory of $93,091 (raw materials) as of March 31, 2026.
- · 5,424,598 warrants outstanding as of March 31, 2026.
- · Net cash provided by financing activities $1,903,022 in Q1 2026, down significantly from $8,491,764 in Q1 2025.
13-05-2026
This 10-K/A amendment filed on May 13, 2026, updates Item 15 with exhibits including governance documents like bylaws amended September 20, 2024, and the 2025 Stock Option and Incentive Plan approved November 7, 2025. It lists material contracts such as development agreements with Norbrook Laboratories (amended through 2024), multiple lease amendments with TVP, LLC, executive compensation and employment agreements for Michael F. Brigham, Bobbi Jo Brockmann, Timothy C. Fiori, and Olivier te Boekhorst, and various debt instruments with Gorham Savings Bank, Maine Technology Institute, and Maine Community Bank. No financial performance data, period comparisons, or operational metrics are provided.
- · Certificate of Amendment to Certificate of Incorporation effective June 11, 2020.
- · Insider Trading Policy adopted December 11, 2024.
- · Employment Agreement with Olivier te Boekhorst dated September 29, 2025.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: S&P 500 Industrials Sector SEC Filings
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals